Cristina Smolenschi

5PUBLICATIONS
71CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 03, 2026
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé

|Jan 09, 2025
A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer.

Emma J West, Alain Sadoun, Kaidre Bendjama

|Oct 26, 2024
KRAS, a New Target for Precision Medicine in Colorectal Cancer?

Alice Boilève, Cristina Smolenschi, Aurélien Lambert

|Sep 03, 2024
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies.

Francesco Facchinetti, Yohann Loriot, Floriane Brayé

|Feb 22, 2023
Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?

Cristina Smolenschi, Elie Rassy, Johan Pallud

Pageof 1